Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Ironwood Pharmaceuticals Inc’s stock clocked out at $1.41, down -7.84% from its previous closing price of $1.53. In other words, the price has decreased by -$7.84 from its previous closing price. On the day, 14.62 million shares were traded. IRWD stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.37.
Ratios:
To gain a deeper understanding of IRWD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.82. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 4.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Market Perform rating and assigned the stock a target price of $5.
On August 08, 2024, CapitalOne Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $4.
On January 17, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.Craig Hallum initiated its Buy rating on January 17, 2024, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when MCCOURT Thomas A sold 139,064 shares for $1.76 per share. The transaction valued at 244,753 led to the insider holds 1,160,634 shares of the business.
Silver Ronald sold 12,048 shares of IRWD for $21,204 on Feb 10 ’25. The Principal Accounting Officer now owns 279,655 shares after completing the transaction at $1.76 per share. On Feb 10 ’25, another insider, Shetzline Michael, who serves as the SVP, CMO, Head-Res&Drug of the company, sold 41,269 shares for $1.76 each. As a result, the insider received 72,633 and left with 554,007 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 225639472 and an Enterprise Value of 735746496. As of this moment, Ironwood’s Price-to-Earnings (P/E) ratio for their current fiscal year is 130.56, and their Forward P/E ratio for the next fiscal year is 6.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.64. Its current Enterprise Value per Revenue stands at 2.094 whereas that against EBITDA is 7.396.
Stock Price History:
The Beta on a monthly basis for IRWD is 0.28, which has changed by -0.83234245 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, IRWD has reached a high of $9.23, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is -39.35%, while the 200-Day Moving Average is calculated to be -66.78%.
Shares Statistics:
It appears that IRWD traded 3.04M shares on average per day over the past three months and 3468060 shares per day over the past ten days. A total of 160.03M shares are outstanding, with a floating share count of 155.19M. Insiders hold about 3.02% of the company’s shares, while institutions hold 102.98% stake in the company. Shares short for IRWD as of 1740700800 were 12052713 with a Short Ratio of 3.97, compared to 1738281600 on 10754287. Therefore, it implies a Short% of Shares Outstanding of 12052713 and a Short% of Float of 14.56.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
